Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]

Core Viewpoint - Oracle Corporation (NYSE:ORCL) is recognized as one of the best kid-friendly stocks to invest in, despite recent challenges and adjustments in its market outlook [1]. Group 1: Analyst Insights - Jefferies analyst Brent Thill has reduced the price target for ORCL from $400 to $320 while maintaining a Buy rating, reflecting a more conservative view on the company's AI-related activities and margin assumptions [2]. - The revision is influenced by expectations for pipeline expansion and performance in calendar year 2026, supported by partner survey data indicating growing optimism regarding AI [2]. - For fiscal Q3, key benchmarks include projected 86% growth in ORCL Cloud Infrastructure and approximately $18 billion in net remaining performance obligations, which contributed to the conservative target adjustment [2]. Group 2: Workforce Adjustments - Oracle Corporation is planning large-scale layoffs that may affect thousands of employees across various divisions due to financial pressures from an extensive AI data center expansion [3]. - The layoffs are expected to target roles likely to decline because of AI-related automation and may be broader than the company's usual rolling reductions [3]. - Workforce adjustments could begin as early as this month, with a review of open positions within the cloud division leading to a slowdown or pause in hiring [4]. Group 3: Company Overview - Oracle Corporation is a global technology company that provides software, cloud services, and hardware solutions for database management, enterprise applications, and business operations [5].

Group 1 - Aegon Ltd. (NYSE:AEG) is identified as an oversold stock with a recent price target increase by Citi to EUR 8.02 from EUR 7.69, maintaining a Buy rating [1] - Aegon has expanded its operations in China by establishing Aegon Insurance Asset Management Company (Aegon IAMC), which began operations on February 2, 2026, after obtaining its insurance asset management license [2][4] - The launch of Aegon IAMC allows the company to access long-term investment opportunities in China, focusing on sectors like infrastructure and renewable energy, aligning with its long-term investment strategy [3] Group 2 - In the second half of 2025, Aegon's net result was €375 million, a decrease from €741 million in the second half of 2024, while the full-year net result increased by 45% to €980 million [4] - Operating results for Aegon rose by 11% in the second half to €858 million and by 15% for the full year to €1.7 billion, supported by all business units and favorable market conditions [4] - Aegon's valuation equity increased by 7% to €9.06 per share, with capital generation reaching €711 million in the second half and €1.3 billion for the full year, alongside a proposed final dividend of €0.21 [4]

Core Viewpoint - The Progressive Corporation (NYSE:PGR) is identified as one of the most oversold insurance stocks, with analysts suggesting it may present a buying opportunity despite challenges in the auto insurance market [1]. Group 1: Price Target and Analyst Ratings - BMO Capital has reduced its price target for PGR from $232 to $208 while maintaining a Market Perform rating, citing limited pricing power and low single-digit claims inflation as contributing factors [2]. - The firm anticipates that operational efficiencies from AI adoption may help offset some of the pricing challenges faced by PGR [2]. Group 2: Revenue Forecasts and Market Challenges - BMO expects consensus revenue forecasts for PGR to decline further due to the company's diminishing ability to raise auto insurance premiums, reflecting ongoing pricing challenges in the market [3]. Group 3: Financial Management and Dividends - The Board of Directors of PGR announced a quarterly dividend of $0.10 per common share, indicating the company's strong financial position and commitment to returning value to shareholders [5]. - The dividend will be paid to stockholders on April 10, 2026, for those listed as of April 2, 2026, showcasing the company's focus on balancing operational stability with shareholder returns [5]. Group 4: Company Overview - The Progressive Corporation is a U.S. insurance company that provides personal and commercial auto, property, and specialty insurance products, both directly and through agents across the nation [6].

Core Viewpoint - Marsh & McLennan Companies, Inc. (NYSE:MRSH) is identified as one of the most oversold stocks in the insurance sector, with analysts suggesting it presents a buying opportunity despite recent market selloffs related to AI concerns [1][2]. Group 1: Analyst Insights - Barclays has adjusted its price target for MRSH to $209 from $210 while maintaining an Overweight rating, indicating confidence in the stock despite recent selloffs [2]. - The selloff in the insurance brokerage sector is viewed as excessive by Barclays, which believes MRSH can benefit from efficiency gains and that current valuations do not fully reflect the brokerage model's durability [2][6]. Group 2: Product Development - On March 2, Marsh & McLennan launched Network Navigator, a healthcare pricing technology that allows employers to assess costs and network performance based on various criteria [3]. - This tool aims to improve network evaluation methods by providing comprehensive provider-level analytics, addressing gaps in current techniques that rely on insufficient data [4]. Group 3: Company Overview - Marsh & McLennan is a global professional services firm that offers risk management, insurance brokerage, consulting, and advisory services across various industries [4].

Market Overview - U.S. stocks have been drifting lower over the past two weeks due to rising concerns about inflation and interest rates, exacerbated by the conflict with Iran and increasing oil prices [1] - Investors are preparing for a potential further decline in the market this week [1] Volatility Indicators - The gap between the Cboe Volatility Index (VIX) and the S&P 500's realized volatility was 10 points wider than expected last week, indicating heightened market fear [2] - The VIX, known as Wall Street's "fear gauge," finished above 27, which is approximately one standard deviation above its long-term average, suggesting increased demand for market protection [5] Market Sentiment - Despite a low one-month S&P 500 realized volatility of 12% and the index being within 5% of its all-time high, the market does not fully reflect the fear expressed in the options market [3] - Only 31% of the S&P 500 components were above their 50-day moving average, indicating a fragile market condition, the lowest level since November 20 [6] Trading Behavior - Options traders are actively seeking protection, while systematic funds are expected to reduce their stock exposure in the coming week [4]

Core Viewpoint - Arthur J. Gallagher & Co. (AJG) is identified as one of the most oversold insurance stocks, with analysts suggesting it presents a buying opportunity [1]. Group 1: Analyst Upgrades and Market Sentiment - Barclays upgraded AJG from Underweight to Overweight and increased the price target from $247 to $262, indicating a positive outlook despite recent market declines due to AI disruption concerns [2]. - Barclays argues that the market's reaction to AI disruption fears is excessive, as current valuations reflect slower growth while underestimating the brokerage model's resilience and AI's potential to enhance efficiency and margins [2]. Group 2: Company Developments - Risk Placement Services, Inc. (RPS), a division of AJG, acquired S Philips Surety & Insurance Services, expanding its product offerings and strengthening regional surety expertise, although the terms of the transaction remain undisclosed [4]. - AJG is characterized as a global insurance brokerage and risk management firm, providing a range of services including property, casualty, employee benefits, and consulting to clients worldwide [5]. Group 3: Investment Considerations - While AJG is recognized for its stability and potential productivity gains through AI integration, there are suggestions that other AI stocks may offer greater upside potential with less downside risk [6].

Core Viewpoint - Brown & Brown, Inc. (NYSE:BRO) is identified as one of the most oversold insurance stocks, with analysts suggesting it may present a buying opportunity despite recent concerns regarding AI disruption in the insurance brokerage industry [1][2]. Group 1: Analyst Insights - Barclays has lowered the price target for BRO from $82 to $80 while maintaining an Equal Weight rating, indicating that the recent stock decline may be overstated [2][5]. - The firm believes that current valuations reflect slower growth but do not adequately account for the durability of the brokerage business model and the potential positive impact of AI on margins and productivity [2][5]. Group 2: Company Developments - On February 17, 2026, Brown & Brown Dealer Services (BBDS) acquired the assets of The Protectorate Group Insurance Agency, which operates as American Adventure Insurance, enhancing its dealership-focused insurance solutions [3][5]. - The acquisition is expected to improve BBDS's capabilities and broaden its product offerings, aligning with the company's dealer-centric strategy [5]. Group 3: Company Overview - Brown & Brown, Inc. is a U.S. insurance brokerage firm that provides risk management, insurance, and related consulting services to businesses, individuals, and public entities across the nation [6].

Group 1 - Willis Towers Watson Public Limited Company (NASDAQ: WTW) is identified as one of the most oversold stocks to invest in according to analysts [1] - Barclays upgraded WTW to Equal Weight from Underweight and raised its price target to $341 from $318, citing that concerns over AI-related disruption in the insurance brokerage industry are exaggerated [2] - The company’s specialist strategy has shown more resilience than expected, and existing valuations do not fully reflect the strength of the brokerage model and the potential for AI to enhance efficiency and margins [2] Group 2 - WTW declared a quarterly cash dividend of $0.96 per share for the quarter ending December 31, 2025, marking a 4% increase from the previous quarter [3] - The dividend will be distributed to stockholders as of March 31, 2026, aligning with the company's strategy of returning capital to shareholders while maintaining financial discipline [4] - WTW operates as a global advisory, broking, and solutions company, providing risk management, insurance brokerage, and human capital consulting services [5]

Core Insights - Ryan Specialty Holdings, Inc. (NYSE:RYAN) is identified as one of the most oversold stocks in the insurance sector, according to analysts [1] Financial Performance - For Q4 2025, Ryan Specialty reported a 13.2% year-over-year increase in sales, reaching $751.2 million, driven by acquisitions, higher contingent commissions, and 6.6% organic revenue growth [3] - Despite the sales increase, net income fell by 26.6% to $31.2 million due to higher operational and interest costs [3] - Adjusted net income for the year rose by 0.5% to $124 million, while adjusted EBITDAC increased by 2.9% to $222.3 million [4] - Total revenue for the year grew by 21.3% to $3.05 billion, with adjusted diluted EPS increasing by 9.5% to $1.96, indicating sustained growth in the specialty insurance platform [4] Market Sentiment - Barclays has lowered the price target for RYAN from $52 to $45, maintaining an Overweight rating, citing concerns over AI-related disruptions in the insurance brokerage industry, although they believe the current valuation is excessive [2][8] - The firm argues that current valuations reflect slower growth expectations while underestimating the durability of the brokerage model and the potential for AI to enhance margins and efficiency [2]